Atopic Dermatitis Clinical Trials
A listing of Atopic Dermatitis medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.
Found 199 clinical trials
Study of Ruxolitinib Cream in Children With Atopic Dermatitis
Open-label, BID application to all affected areas identified at BSLN for 4 weeks (maximum use trial (MUsT) period). The next 4 weeks (treatment extension period) will be applied BID to active lesions only for the next 4 weeks for a total treatment period of 8 weeks. Eligible participants will be …
- 0 views
- 21 Mar, 2022
- 16 locations
A research study for people with moderate to severe atopic dermatitis.
A Phase 2 Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Subcutaneous Lirentelimab in Adult Subjects with Moderate-to-Severe Atopic Dermatitis
- 0 views
- 11 Jul, 2022
- 1 location
INCB 18424-303: Topical Ruxolitinib Evaluation in Atopic Dermatitis Study 1 (TRuE-AD1)
A Phase 3, randomized (2:2:1), double-blind, 8-week vehicle control efficacy and safety study of ruxolitinib followed by a randomized, double-blind, 44-week long term safety (LTS) extension period. In the LTS period, participants initially randomized to vehicle will receive either ruxolitinib 0.75% or 1.5% cream. All participants will have follow-up assessments …
- 582 views
- 10 May, 2022
- 19 locations
A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Dose-Ranging Study Investigating the Efficacy, Safety, and Pharmacokinetic Profile of ANB020 Administered to Adult Subjects with Moderate-to-Severe Atopic Dermatitis
compared to placebo in adult subjects with moderate to severe atopic dermatitis (AD). This study will also assess the safety, tolerability, and pharmacokinetics of Etokimab. The study will have a
- 61 views
- 23 Nov, 2020
- 1 location
We are currently recruiting participants for the BLUEPRINT study. This study investigates the effectiveness, safety, and tolerability of the drug BLU-5937 for chronic itch in people with eczema.
eczema and overall health will be done with the study team.
- 82 views
- 10 Dec, 2020
- 25 locations
INCB 18424-304: Topical Ruxolitinib Evaluation in Atopic Dermatitis Study 2 (TRuE-AD2) for 304
A Phase 3, randomized (2:2:1), double-blind, 8-week vehicle control efficacy and safety study of ruxolitinib followed by a randomized, double-blind, 44-week long term safety (LTS) extension period. In the LTS period, participants initially randomized to vehicle will receive either ruxolitinib 0.75% or 1.5% cream. All participants will have follow-up assessments …
- 423 views
- 03 May, 2022
- 11 locations
A 3-week study to evaluate a generic non-steroidal topical cream for the treatment of eczema.
A 3-week study to evaluate a generic non-steroidal topical cream for the treatment of eczema.
- 190 views
- 08 Nov, 2020
- 1 location
A 4-week study to evaluate a generic non-steroidal topical cream for the treatment of eczema.
A 4-week study to evaluate a generic non-steroidal topical cream for the treatment of eczema.
- 109 views
- 08 Nov, 2020
- 1 location
Integument-2 study
We are currently recruiting pediatric and adult patients with mild to moderate atopic dermatitis (eczema) for a study that investigates the safety and efficacy of the ARQ-151 cream.
- 68 views
- 07 Jul, 2022
- 63 locations
Study 203121: A Randomized, Blinded, Vehicle-Controlled, Dose-Finding Study of GSK2894512 Cream for the Treatment of Atopic Dermatitis
Study 203121: A Randomized, Blinded, Vehicle-Controlled, Dose-Finding Study of GSK2894512 Cream for the Treatment of Atopic Dermatitis
- 446 views
- 23 Nov, 2020
- 1 location